Showing results (81-90 of 162) with videos related to
Sort By:
Pageof 17
Journal of Integrative Neuroscience|July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social BehaviorMichael Bobick, Colin Hanna, John Tyler, et al.Open Journal of Immunology|November 21, 2022
Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis"Kenneth Blum, Catherine A Dennen, Eric R Braverman, et al.Journal of Systems and Integrative Neuroscience|September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemicKenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.Biomedicines|April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.Biomedical Journal of Scientific & Technical Research|October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid CrisisKenneth Blum, Edward J Modestino, Jennifer Neary, et al.Acta Scientific Neurology|August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight LossEdward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.Psychology Research and Behavior Management|February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case SeriesKeerthy Sunder, Milan T Makale, Miles Makale, et al.Journal of Addiction Psychiatry|August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?Kenneth Blum, Catherine Dennen, Paul R Carney, et al.Acta Scientific Neurology|March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?Kenneth Blum, Ali Raza, Tiffany Schultz, et al.International Journal of Environmental Research and Public Health|January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive BehaviorsAshim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.Pageof 17